Author Bios



Fumiko Chino, MD

Fumiko Chino, MD

Dr. Chino is chief resident at Duke University Radiation Oncology, Durham, NC.


G. Daniel Grass, MD, PhD; Matthew N. Mills, MD; Jacob G. Scott, MD, DPhil; Steven A. Eschrich, PhD; Javier Torres-Roca, MD

G. Daniel Grass, MD, PhD; Matthew N. Mills, MD; Jacob G. Scott, MD, DPhil; Steven A. Eschrich, PhD; Javier Torres-Roca, MD

Dr. Grass is an assistant member and Dr. Mills is a radiation oncology resident, Department of Radiation Oncology, Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Dr. Scott is an assistant professor, Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, OH. Dr. Eschrich is a senior member, Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute. Dr. Torres-Roca is a senior member, Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute. Disclosure: Drs. Scott, Torres-Roca and Eschrich report intellectual property (IP); Drs. Scott and Torres-Roca report IP regarding genomically adjusted radiation dose (GARD), and Drs. Eschrich and Torres-Roca report stock in Cvergenx. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.


Gary M. Freedman, MD; Lilie Lin, MD

Gary M. Freedman, MD; Lilie Lin, MD

Dr. Freedman is a professor and Dr. Lin is an associate professor at the Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA.

Gaurav Saigal, MD, Jennifer Runco Therrien, MD, and Frank Kuo, BS

Gaurav Saigal, MD, Jennifer Runco Therrien, MD, and Frank Kuo, BS

Dr. Saigal and Dr. Therrien are with the Department of Radiology, Jackson Memorial Hospital, and the University of Miami Miller School of Medicine, Miami, FL, and Mr. Kuo is with the University of Miami Miller School of Medicine, Miami FL.


Gleb A. Kuzmin, PhD;* Mishka Gidwani, BS;* Tianjun Ma, PhD;* Tingliang Zhuang, PhD; Mohamed E. Abazeed, MD, PhD

Gleb A. Kuzmin, PhD;* Mishka Gidwani, BS;* Tianjun Ma, PhD;* Tingliang Zhuang, PhD; Mohamed E. Abazeed, MD, PhD

*These authors contributed equally to this work. Dr. Kuzmin is a physics resident, Department of Radiation Oncology, Cleveland Clinic, OH. Ms. Gidwani is a graduate student, Department of Translational Hematology Oncology Research, Cleveland Clinic. Dr. Ma is a physics resident, Department of Radiation Oncology, Cleveland Clinic. Dr. Zhuang is a physicist, Department of Radiation Oncology, Cleveland Clinic. Dr. Abazeed is the director, Center for Precision Radiotherapy, Department of Radiation Oncology, and assistant professor, Cleveland Clinic Lerner College of Medicine. Disclosure: None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere. Dr. Abazeed reports grant support from Siemens Healthcare, Malvern, PA.


Hassan Beydoun, MD; Benjamin Weinberg, MD; Newton Hurst, MD; PhD, Nabiha Khoury, MD; Shabbir Ahmed, MD; Thomas Kasza, MS; Michael L. Cher, MD; Keqin Tang, MD, PhD, MS

Hassan Beydoun, MD; Benjamin Weinberg, MD; Newton Hurst, MD; PhD, Nabiha Khoury, MD; Shabbir Ahmed, MD; Thomas Kasza, MS; Michael L. Cher, MD; Keqin Tang, MD, PhD, MS

Dr. Beydoun is a PGY4 resident, Section of Radiation Oncology, and Dr. Cher is professor and chair, Department of Urology, Karmanos Cancer Institute, Detroit, MI. Dr. Weinberg is an attending radiation oncologist, Department of Radiation Oncology, Pardee Cancer Center, Hendersonville, NC. Dr. Hurst is an attending radiation oncologist, Department of Radiation Oncology, Loyola University Medical Center, IL. Dr. Khoury is section chief, Section of Pathology; Dr. Ahmed is section chief, Section of Medical Oncology; Mr. Kasza is a therapeutic medical physicist, Section of Radiation Oncology; and Dr. Tang is an attending radiation oncologist, Section of Radiation Oncology, John D. Dingell Veterans Affairs Medical Center, Detroit, MI.

Disclosure: The authors have no conflicts of interest to disclose. None of the authors received outside funding for the production of this original manuscript and no part of this article has been previously published elsewhere.


Hena Joshi, MS3, BS, Jay Radhakrishnan, MD, Eran Rotem, MD, and Hal Gregory Bowers, MD

Hena Joshi, MS3, BS, Jay Radhakrishnan, MD, Eran Rotem, MD, and Hal Gregory Bowers, MD

Prepared by Dr. Joshi, Dr. Radhakrishnan, Dr. Rotem, and Dr. Bowers while at the Division of Vascular/Interventional Radiology,Medical College of Georgia, Augusta, GA.


Heva Jasmine Saadatmand, MPH; Cheng-Chia Wu, MD, PhD; and Tony J. C. Wang, MD

Heva Jasmine Saadatmand, MPH; Cheng-Chia Wu, MD, PhD; and Tony J. C. Wang, MD

Miss Saadatmand is a fourth-year medical student, Dr. Wu is a resident physician in radiation oncology, and Dr. Wang is assistant professor of radiation oncology, all in the Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University Medical Center, New York, NY. Miss Saadatmand and Dr. Wu are co-first authors.

Hilario Yankey; Jordan M. Anaokar, MD; Joshua E. Meyer, MD

Hilario Yankey; Jordan M. Anaokar, MD; Joshua E. Meyer, MD

Mr. Yankey is a fourth-year medical student at Lewis Katz School of Medicine, Temple University, Philadelphia, PA. Dr. Anaokar is assistant professor of radiology, Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, PA. Also at Fox Chase, Dr. Meyer is associate professor of radiation oncology, Department of Radiation Oncology. Disclosure: The authors have no conflicts of interest to disclose, and no part of this article has been previously published elsewhere. Acknowledgements: This publication was supported by grant number P30 CA006927 from the National Cancer Institute, NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

Copyright © Anderson Publishing, Ltd

 2020
    Agility CMS